{"id":5801,"date":"2020-11-19T15:48:55","date_gmt":"2020-11-19T14:48:55","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=5801"},"modified":"2021-05-20T10:27:50","modified_gmt":"2021-05-20T09:27:50","slug":"approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/","title":{"rendered":"Conf\u00e9rence : &#8220;Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance&#8221;, 16 septembre 2021, Romainville (Paris), Biocitech Technology Park"},"content":{"rendered":"\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Objectifs de la journ\u00e9e<\/strong><\/h3>\n\n\n\n<p>Depuis plusieurs ann\u00e9es nous ne pouvons que constater la mont\u00e9e irr\u00e9sistible de l\u2019antibior\u00e9sistance des souches bact\u00e9riennes pathog\u00e8nes : un fl\u00e9au omnipr\u00e9sent mettant potentiellement en danger la vie de millions de personnes humaines et d\u2019animaux dans le monde.<\/p>\n\n\n\n<p>Lutter contre l\u2019antibior\u00e9sistance n\u00e9cessite une approche globale en sant\u00e9 humaine, mais aussi en sant\u00e9 animale et environnementale (\u00ab&nbsp;one health&nbsp;\u00bb). Seule cette approche transversale et multidisciplinaire impliquant pr\u00e9vention, diagnostic et th\u00e9rapeutique permettra de la comprendre, la caract\u00e9riser et \u00e0 terme de l\u2019\u00e9radiquer.<\/p>\n\n\n\n<p>A la suite du premier colloque organis\u00e9 en 2016, <a href=\"https:\/\/asso.adebiotech.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">Adebiotech<\/a>, propose une nouvelle journ\u00e9e d\u00e9di\u00e9e aux <strong>approches innovantes dans la lutte contre l\u2019antibior\u00e9sistance<\/strong>. Au cours de cette journ\u00e9e de pr\u00e9sentations et de d\u00e9bats, des acteurs de la recherche acad\u00e9mique et industrielle viendront mettre en lumi\u00e8re certaines propositions innovantes qui participent \u00e0 cette lutte, dans l\u2019approche \u00ab&nbsp;ONE HEALTH&nbsp;\u00bb dont nous avons \u00e9t\u00e9 les pionniers en France.<\/p>\n\n\n\n<p>Seront abord\u00e9es les actions pr\u00e9ventives (microbiotes, immunostimulation, nouveaux vaccins\u2026), les innovations dans le domaine des diagnostics (IA et Big data, m\u00e9tag\u00e9nomique, nouveaux diagnostics rapides\u2026), certaines nouvelles approches th\u00e9rapeutiques (phagoth\u00e9rapie, peptides antimicrobiens, bact\u00e9riocines\u2026) et une table ronde\/d\u00e9bat sur la mise sur le march\u00e9 des nouveaux traitements, leur financement et les aspects r\u00e9glementaires.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Participants concern\u00e9s<\/strong><\/h3>\n\n\n\n<p>Cette journ\u00e9e s\u2019adresse \u00e0 tous les acteurs du domaine et les personnes concern\u00e9es par ce probl\u00e8me de sant\u00e9 publique majeur&nbsp;: scientifiques acad\u00e9miques et industriels, m\u00e9decins et personnel de sant\u00e9, nutrionnistes, v\u00e9t\u00e9rinaires, \u00e9pid\u00e9miologistes, journalistes scientifiques, membres des organismes de r\u00e9glementation\u2026<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Sessions et programme<\/strong><\/h3>\n\n\n\n<p>Session 1 \u2013 Actions pr\u00e9ventives<\/p>\n\n\n\n<p>Session 2 \u2013 Innovations Diagnostics<\/p>\n\n\n\n<p>Session 3 \u2013 Approches th\u00e9rapeutiques<\/p>\n\n\n\n<p>Table Ronde \u2013 Mise sur le march\u00e9 de nouveaux produits innovants : \u00e9volution de la r\u00e8glementation, financements et \u00e9conomie de la sant\u00e9<\/p>\n\n\n\n<p>Programme du colloque (rubrique &#8220;Program&#8221; dans le menu bleu) : <a rel=\"noreferrer noopener\" href=\"https:\/\/asso.adebiotech.org\/approches-innovantes-dans-la-lutte-contre-lantibioresistance\/\" target=\"_blank\">consultable ici<\/a><\/p>\n\n\n\n<p><em>Inscriptions ouvertes prochainement<\/em>, pour en savoir plus, contactez l&#8217;\u00e9quipe organisatrice d&#8217;Adebiotech :<\/p>\n\n\n\n<p>+ 33 (0) 1 57 42 34 61<\/p>\n\n\n\n<p>+ 33 (0) 7 67 43 90 93<\/p>\n\n\n\n<p>adebiotech@adebiotech.org<\/p>\n\n\n\n<p><a href=\"https:\/\/asso.adebiotech.org\/approches-innovantes-dans-la-lutte-contre-lantibioresistance\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lien vers le colloque<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Objectifs de la journ\u00e9e Depuis plusieurs ann\u00e9es nous ne pouvons que constater la mont\u00e9e irr\u00e9sistible de l\u2019antibior\u00e9sistance des souches bact\u00e9riennes pathog\u00e8nes : un fl\u00e9au omnipr\u00e9sent mettant potentiellement en danger la vie de millions de personnes humaines et d\u2019animaux dans le monde. Lutter contre l\u2019antibior\u00e9sistance n\u00e9cessite une approche globale en sant\u00e9 humaine, mais aussi en sant\u00e9 [&hellip;]<\/p>\n","protected":false},"author":139,"featured_media":5805,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[31,35],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Conf\u00e9rence : &quot;Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance&quot;, 16 septembre 2021, Romainville (Paris), Biocitech Technology Park - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Conf\u00e9rence : &quot;Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance&quot;, 16 septembre 2021, Romainville (Paris), Biocitech Technology Park - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-19T14:48:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-20T09:27:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1720\" \/>\n\t<meta property=\"og:image:height\" content=\"480\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"\u00c9milie Noguez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\u00c9milie Noguez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/\"},\"author\":{\"name\":\"\u00c9milie Noguez\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\"},\"headline\":\"Conf\u00e9rence : &#8220;Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance&#8221;, 16 septembre 2021, Romainville (Paris), Biocitech Technology Park\",\"datePublished\":\"2020-11-19T14:48:55+00:00\",\"dateModified\":\"2021-05-20T09:27:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/\"},\"wordCount\":371,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg\",\"articleSection\":[\"Actualit\u00e9s\",\"Ev\u00e8nements &amp; Colloques\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/\",\"name\":\"Conf\u00e9rence : \\\"Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance\\\", 16 septembre 2021, Romainville (Paris), Biocitech Technology Park - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg\",\"datePublished\":\"2020-11-19T14:48:55+00:00\",\"dateModified\":\"2021-05-20T09:27:50+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg\",\"width\":1720,\"height\":480,\"caption\":\"Cr\u00e9dit : Adebiotech\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infos pratiques &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Actualit\u00e9s\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Conf\u00e9rence : &#8220;Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance&#8221;, 16 septembre 2021, Romainville (Paris), Biocitech Technology Park\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3\",\"name\":\"\u00c9milie Noguez\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Conf\u00e9rence : \"Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance\", 16 septembre 2021, Romainville (Paris), Biocitech Technology Park - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/","og_locale":"fr_FR","og_type":"article","og_title":"Conf\u00e9rence : \"Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance\", 16 septembre 2021, Romainville (Paris), Biocitech Technology Park - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2020-11-19T14:48:55+00:00","article_modified_time":"2021-05-20T09:27:50+00:00","og_image":[{"width":1720,"height":480,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg","type":"image\/jpeg"}],"author":"\u00c9milie Noguez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"\u00c9milie Noguez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/"},"author":{"name":"\u00c9milie Noguez","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3"},"headline":"Conf\u00e9rence : &#8220;Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance&#8221;, 16 septembre 2021, Romainville (Paris), Biocitech Technology Park","datePublished":"2020-11-19T14:48:55+00:00","dateModified":"2021-05-20T09:27:50+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/"},"wordCount":371,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg","articleSection":["Actualit\u00e9s","Ev\u00e8nements &amp; Colloques"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/","name":"Conf\u00e9rence : \"Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance\", 16 septembre 2021, Romainville (Paris), Biocitech Technology Park - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg","datePublished":"2020-11-19T14:48:55+00:00","dateModified":"2021-05-20T09:27:50+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/11\/Comprimes.jpg","width":1720,"height":480,"caption":"Cr\u00e9dit : Adebiotech"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/approches-innovantes-dans-la-lutte-contre-lantibioresistance-1er-juillet-2021-romainville-paris-biocitech-technology-park\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Infos pratiques &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/"},{"@type":"ListItem","position":3,"name":"Actualit\u00e9s","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/informations-et-communications\/actualites\/"},{"@type":"ListItem","position":4,"name":"Conf\u00e9rence : &#8220;Approches Innovantes dans la lutte contre l\u2019antibior\u00e9sistance&#8221;, 16 septembre 2021, Romainville (Paris), Biocitech Technology Park"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/6ae79ca06cbeaec66ef5e976b54606b3","name":"\u00c9milie Noguez"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-12 14:37:09","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/5801"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/139"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=5801"}],"version-history":[{"count":13,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/5801\/revisions"}],"predecessor-version":[{"id":8523,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/5801\/revisions\/8523"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/5805"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=5801"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=5801"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=5801"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}